Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes

Brain Research Bulletin

Volumn 104, Issue , 2014, Pages 60-73

  Rapôso, Catarina ^a   Luna, Rayana Leal de Almeida ^b   Nunes, Ana Karolina Santana ^b   Thomé, Rodolfo ^a   Peixoto, Christina Alves ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Adhesion molecules; Astrocytes; Cerebellum; Microglia; Oligodendocytes; Sildenafil

Indexed keywords

BIOLOGICAL MARKER; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FAST BLUE; GLIAL FIBRILLARY ACIDIC PROTEIN; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; MYELIN; NITRIC OXIDE; NITRITE; SILDENAFIL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; MOUSE; MYELINATION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; C57BL MOUSE; GENETICS; GLIA; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MYELIN SHEATH; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; CEREBELLUM; CYCLIC GMP; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NEUROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION;

EID: 84899856823     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.04.002     Document Type: Article

References (62)

1. Agullo L., Baltrons M.A., Garcia A. Calcium-dependent nitric oxide formation in glial cells. Brain Res. 1995, 686:160-168.
2. Arnett H.A., Hellendall R.P., Matsushima G.K., Suzuki K., Laubach V.E., Sherman P., Ting J.P. The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J. Immunol. 2002, 168:427-433.
3. Baratti C.M., Boccia M.M. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav. Pharmacol. 1999, 10:731-737.
4. Bellamy T.C., Garthwaite J. Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J. Biol. Chem. 2001, 276:4287-4292.
5. Benjamins J.A., Nedelkoska L. Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury. Neurochem. Res. 2007, 32:321-329.
6. Borán M.S., García A. The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes. J. Neurochem. 2007, 102:216-230.
7. Borán M.S., Baltrons M.A., García A. The ANP-cGMP-protein kinase G pathway a phagocytic phenotype but decreases inflammatory gene expression in microglial cells. Glia 2008, 56:394-411.
8. Danilov A.I., Andersson M., Bavand N., Wiklund N.P., Olsson T., Brundin L. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J. Neuroimmunol. 2003, 136:112-118.
9. -) before and after pentylenetetrazole kindling. Pharmacol. Biochem. Behav. 2006, 85:804-812.
10. Derbyshire E.R., Marletta M.A. Biochemistry of soluble guanylate cyclase. Handb. Exp. Pharmacol. 2009, 191:17-31.
11. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 1998, 160:2940-2946.
12. Forshammar J., Block L., Lundborg C., Biber B., Hansson E. Naloxone and ouabain in ultralow concentrations restore Na+/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes. J. Biol. Chem. 2011, 286:31586-31597.
13. Forshammar J., Jörneberg P., Biörklund U., Westerlund A., Lundborg C., Biber B., Hansson E. Anti-inflammatory substances can influence some glial cell types but not others: cytokine release from microglia. Brain Res. 2013, (in press). 10.1016/j.brainres.2013.09.052.
14. Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does neuroinflammation fan the flame in neurodegenerative diseases?. Mol. Neurodegener. 2009, 4:47.
15. Gay F.W., Drye T.J., Dick G.W., Esiri M.M. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997, 120:1461-1483.
16. 15N]nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
17. Greenwood J., Etienne-Manneville S., Adamson P., Couraud P.O. Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul. Pharmacol. 2002, 38:315-322.
18. Huang P.L. Mouse models of nitric oxide synthase deficiency. J Am Soc Nephrol 2000, 11:S120-S123.
19. Huang P.L., Dawson T.M., Bredt D.S., Snyder S.H., Fishman M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286.
20. Huang P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (Lond) 1995, 377:239-242.
21. Kahl K.G., Zielased J., Uttenthal L.O., Rodrigo J., Toyka K.V., Schmidt H.H. Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J. Neurosci. Res. 2003, 73:198-205.
22. Ke X., Terashima M., Nariai Y., Nakashima Y., Nabika T., Tanigawa Y. Nitric oxide regulates actin reorganization through cGMP and Ca(2+)/calmodulin in RAW 264.7 cells. Biochim. Biophys. Acta 2001, 1539:101-113.
23. Klotz L., Diehl L., Dani I., Neumann H., von Oppen N., Dolf A., Endl E., Klockhether T., Engelhardt B., Knolle P. Brain endothelial PPARgamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro. J. Neuroimmunol. 2007, 190:34-43.
24. Kyritsis N., Kizil C., Brand M. Neuroinflammation and central nervous system regeneration in vertebrates. Trends Cell Biol. 2014, 24:128-135.
25. Lartey F.M., Ahn G.O., Shen B., Cord K.T., Smith T., Chua J.Y., Rosenblum S., Liu H., James M.L., Chernikova S., Lee S.W., Pisani L.J., Tirouvanziam R., Chen J.W., Palmer T.D., Chin F.T., Guzman R., Graves E.E., Loo B.W. PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06. Mol. Imaging Biol. 2014, 16:109-117.
26. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. U S A 1995, 92:10688-10692.
27. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 1999, 98:77-88.
28. Lieb K., Engels S., Fiebich B.L. Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem. Int. 2003, 42:131-137.
29. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., Chen H., Mudgett T.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650.
30. Manson S.C., Burke G., Voets N., Palace J., Matthews P.M. Effect of sildenafil citrate on CBF and BOLD activation in multiple sclerosis patients. 21st congress of the European Committee for the Treatment and Research in Multiple Sclerosis; Poster No. 237 Thessaloniki, Greece 2005.
31. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980, 85:890-902.
32. Mc Guire C., Prinz M., Beyaert R., van Loo G. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology. Trends Mol. Med. 2013, 19:604-613.
33. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
34. Murthy K.S. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. Biochem. J. 2001, 360:199-208.
35. Nossaman B.D., Kadowitz P.J. Stimulators of soluble guanylyl cyclase: future clinical indications. Ochsner J. 2013, 13:147-156.
36. ®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Cytokine 2012, 60:540-551.
37. Papapetropoulos A., Abou-Mohamed G., Marczin N., Murad F., Caldwell R.W., Catravas J.D. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta. Br. J. Pharmacol. 1996, 118:1359-1366.
38. Pifarre P., Prado J., Baltrons M.A., Giralt M., Gabarro P., Feinstein D.L., Hidalgo J., Garcia A. Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis. Acta Neuropathol. 2011, 121:499-508.
39. Prickaerts J., van Staveren W.C., Sik A., Markerink-van Ittersum M., Niewöhner U., van der Staay F.J., Blokland A., de Vente J. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002, 113:351-361.
40. Puzzo D., Privitera L., Leznik E., Fà M., Staniszewski A., Palmeri A., Arancio O. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 2008, 28:14537-14545.
41. Pyriochou A., Papapetropoulos A. Soluble guanylyl cyclase: more secrets revealed. Cell. Signal. 2005, 17:407-413.
42. Ramesh G., Maclean A.G., Philipp M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013, 2013:480739.
43. Raposo C., Nunes A.K., Luna R.L., Araújo S.M., Cruz-Höfling M.A., Peixoto C.A. Sildenafil (Viagra) protective effects on neuroinflammation: the role of iNOS/NO system in an inflammatory demyelination model. Mediators Inflamm. 2013, 2013:321460.
44. RapÔso C., Odorissi P.A.M., Oliveira A.L.R., Aoyama H., Ferreira C.V., Verinaud L., Fontana K., Ruela-de-Souza R.R., Cruz-Höfling M.A. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem. Res. 2012, 37:1967-1981.
45. Riccitelli G., Rocca M.A., Pagani E., Martinelli V., Radaelli M., Fajini A., Comi G., Filippi M. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. MultScler 2012, 18:1027-1037.
46. Ruuls S.R., Van der Linder S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 1996, 103:467-474.
47. Saraiva K.L., Silva A.K., Wanderley M.I., De Araújo A.A., De Souza J.R., Peixoto C.A. Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion. Int. J. Exp. Pathol. 2009, 90:454-462.
48. Shields S.D., Cheng X., Gasser A., Saab C.Y., Tyrrell L., Eastman E.M., et al. A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis. Ann. Neurol. 2012, 71:186-194.
49. Shimouchi A., Janssens S.P., Bloch D.B., Zapol W.M., Bloch K.D. cAMP regulates soluble guanylate cyclase beta 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am. J. Physiol. 1993, 265:L456-L461.
50. Tsutsui M., Shimokawa H., Morishita T., Nakata S., Sabanai K., Nakashima Y., Yanagihara N. Development of genetically engineered mice lacking all three nitric oxide synthase isoforms. Yakugaku Zasshi 2007, 127:1347-1355.
51. Vollmar A.M., Förster R., Schulz R. Effects of atrial natriuretic peptide on phagocytosis and respiratory burst in murine macrophages. Eur. J. Pharmacol. 1997, 319:279-285.
52. Vollmar A.M. The role of atrial natriuretic peptide in the immune system. Peptides 2005, 26:1086-1094.
53. Wakita H., Tomimoto H., Akiguchi I., Lin J.X., Ihara M., Ohtani R., Shibata M. Ibudilast protect against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res. 2003, 992:53-59.
54. Wang L., Chopp M., Szalad A., Liu Z., Bolz M., Alvarez F.M., Lu M., Zhang L., Cui Y., Zhang R.L., Zhang Z.G. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. Neuroscience 2011, 193:399-410.
55. Wang X., Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 1997, 68:443-456.
56. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (Lond) 1995, 375:408-411.
57. Williams K.C., Hickey W.F. Traffic of hematogenous cells through the central nervous system. Curr. Top. Microbiol. Immunol. 1995, 202:221-245.
58. Woodcock T., Morganti-Kossmann M.C. The role of markers of inflammation in traumatic brain injury. Front. Neurol. 2013, 4:18.
59. Xia X., Xu Z., Hu X., Wu C., Dai Y., Yang L. Impaired iNOS-sGC-cGMP signaling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat. Cell Biochem. Funct. 2012, 30:279-285.
60. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., Pleasure D. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J. Neurochem. 2000, 74:633-640.
61. Yoshioka Y., Takeda N., Yamamuro A., Atsushi K., Maeda S. Nitric oxide inhibits lipopolysaccharide-induced inducible nitric oxide synthase expression and its own production through the cGMP signaling pathway in murine microglia BV-2 cells. J. Pharmacol. Sci. 2010, 113:153-160.
62. Zhao L., Mason N.A., Strange J.W., Walker H., Wilkins M.R. Beneficial effects of phosphodiesterase 5 inhibitor in pulmonary hypertension are influenced by natriuretic peptide activity. Circulation 2003, 107:234-237.